BWAY BrainsWay Ltd.

NASDAQ
$13.31

BrainsWay Ltd. (BWAY) is expected to report earnings on November 16, 2026, before the market open. The consensus earnings estimate is $0.12 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -15.9% since its last earnings release on August 12, 2026.

BrainsWay Beat Consensus Estimates, Raises Guidance to be In-line with Estimates
Wednesday, August 12, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 16
Monday · 7:30 AM ET
Earnings Whisper
-
vs $0.12
Rev est $17.85M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $14.89

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BrainsWay Ltd.

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.